---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-044758"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:57:43.898664+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q2 revenue up 124% to $12.1M; diluted EPS $0.21 vs $(0.02) YoY

## Summary
- Revenue $12.1M, up 124% from $5.4M in Q2 2021; net income $3.5M vs net loss $(0.3M).
- Diluted EPS $0.21 vs $(0.02); adjusted EBITDA $4.7M vs $(0.1M).
- Gross margin improved to 68.6% from 61.1%; cash and equivalents $33.7M.
- Received orders for 10 TransDermal Infusion Systems from Hair Enhancement Centers.
- Affirms expectations for continued Q3 growth and full-year profitability.

## SEC filing metadata
- accession: 0001213900-22-044758
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390022044758/0001213900-22-044758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390022044758/ea163775-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-044758
- JSON: https://secwatch.observer/filing/0001213900-22-044758.json
- Plain text: https://secwatch.observer/filing/0001213900-22-044758.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.